BridgeMD
New treatment option for Occlusal Wear of Teeth
Official title Clinical Evaluation of Hybrid Ceramic Occlusal Veneers Bonded With Two Self Adhesive Resin Cements
ClinicalTrials.gov ID: NCT07017062
What this study is testing
- What it's testing
- This randomized clinical trial aims to evaluate the clinical performance of hybrid ceramic occlusal veneers cemented with two different bonding protocols: a self-adhesive bonding protocol with adhesive enhancement (BeautiLink SA cement with BeautiBond Xtreme adhesive) versus another self-adhesive bonding protocol (RelyX U200 self-adhesive resin cement with 3M UNIVERSAL bond).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Age ≥ 21 years
- Vital teeth
- Sufficient tooth structure for veneer retention
- Willing and able to provide written informed consent
- Ability to attend all follow-up appointments
You likely can't join if
- Patients with active periodontal disease (probing depth \> 4mm, bleeding on probing)
- Patients with severe parafunctional habits (e.g., bruxism confirmed by clinical examination)
- Poor oral hygiene (plaque index \> 30%)
- Pregnancy or nursing
- Systemic diseases affecting treatment outcomes (e.g., uncontrolled diabetes, immunosuppression)
- Known allergies to study materials (ceramic, or resin cement components)
See the full eligibility criteria
- Age ≥ 21 years
- Vital teeth
- Sufficient tooth structure for veneer retention
- Willing and able to provide written informed consent
- Ability to attend all follow-up appointments
- Adequate oral hygiene as determined by the investigator
- Patients with active periodontal disease (probing depth \> 4mm, bleeding on probing)
- Patients with severe parafunctional habits (e.g., bruxism confirmed by clinical examination)
- Poor oral hygiene (plaque index \> 30%)
- Pregnancy or nursing
- Systemic diseases affecting treatment outcomes (e.g., uncontrolled diabetes, immunosuppression)
- Known allergies to study materials (ceramic, or resin cement components)
- Inability to comply with study requirements
- Current participation in other dental clinical trials
- Active orthodontic treatment
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.